Loading...
XNASISPR
Market cap252mUSD
Jan 13, Last price  
4.55USD
1D
-1.76%
1Q
-33.13%
IPO
-36.29%
Name

Ispire Technology Inc

Chart & Performance

D1W1MN
XNAS:ISPR chart
P/E
P/S
1.70
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
152m
+31.40%
63,414,78388,095,418115,605,536151,908,691
Net income
-15m
L+142.15%
2,937,806-1,874,153-6,098,603-14,767,822
CFO
-18m
L+141.40%
5,024,329-7,557,566-7,581,759-18,302,306
Earnings
Feb 19, 2025

Profile

Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited
IPO date
Apr 04, 2023
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2024‑062023‑062022‑062021‑06
Income
Revenues
151,909
31.40%
115,606
31.23%
88,095
38.92%
Cost of revenue
165,803
120,175
89,084
Unusual Expense (Income)
NOPBT
(13,894)
(4,569)
(989)
NOPBT Margin
Operating Taxes
1,282
1,245
1,071
Tax Rate
NOPAT
(15,176)
(5,814)
(2,060)
Net income
(14,768)
142.15%
(6,099)
225.41%
(1,874)
-163.79%
Dividends
(3,363)
(470)
Dividend yield
0.68%
Proceeds from repurchase of equity
12,300
33,067
BB yield
-2.80%
-6.69%
Debt
Debt current
1,208
945
348
Long-term debt
5,596
7,657
348
Deferred revenue
Other long-term liabilities
Net debt
(40,515)
(40,833)
(73,786)
Cash flow
Cash from operating activities
(18,302)
(7,582)
(7,558)
CAPEX
(1,970)
(1,021)
(122)
Cash from investing activities
2,990
(10,154)
(122)
Cash from financing activities
10,083
(16,444)
(3,089)
FCF
(16,188)
(10,554)
(2,026)
Balance
Cash
35,071
49,434
74,481
Long term investments
12,248
Excess cash
39,724
43,654
70,076
Stockholders' equity
(8,761)
5,689
11,767
Invested Capital
46,619
29,922
(134)
ROIC
ROCE
EV
Common stock shares outstanding
54,813
54,222
52,700
Price
8.00
-12.28%
9.12
 
Market cap
438,503
-11.33%
494,508
 
EV
397,988
453,676
EBITDA
(12,177)
(3,461)
(843)
EV/EBITDA
Interest
Interest/NOPBT